-
1 Comment
China National Accord Medicines Corporation Ltd is currently in a long term downtrend where the price is trading 14.4% below its 200 day moving average.
From a valuation standpoint, the stock is 96.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.3.
China National Accord Medicines Corporation Ltd's total revenue rose by 27.3% to $17B since the same quarter in the previous year.
Its net income has increased by 30.8% to $404M since the same quarter in the previous year.
Finally, its free cash flow fell by 169.3% to $-586M since the same quarter in the previous year.
Based on the above factors, China National Accord Medicines Corporation Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE0000009N6 |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Beta | 0.24 |
|---|---|
| Market Cap | 15B |
| PE Ratio | 27.15 |
| Target Price | 25.735 |
| Dividend Yield | 1.4% |
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Western medicine, rehabilitation therapy, and various medical-related resources through retail and medical service stores, as well as chemical drugs, OTC drugs, and health products. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. China National Accord Medicines Corporation Ltd. was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000028.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
